These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15842308)

  • 1. Veterinary pharmacovigilance. Part 5. Causality and expectedness.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):203-11. PubMed ID: 15842308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal products.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):185-201. PubMed ID: 15842307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.
    Woodward KN
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):114-28. PubMed ID: 18060673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterinary pharmacovigilance. Part 6. Predictability of adverse reactions in animals from laboratory toxicology studies.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):213-31. PubMed ID: 15842309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary pharmacovigilance in the European context.
    Keck G
    Ann Ist Super Sanita; 1992; 28(4):425-8. PubMed ID: 1303032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspected adverse drug reactions in the Hungarian veterinary practice between 1982 and 1992.
    Bernáth S; Szászfai M; Kulcsár G; Halász M
    Acta Vet Hung; 1996; 44(4):451-6. PubMed ID: 9141281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterinary pharmacovigilance. Part 3. Adverse effects of veterinary medicinal products in animals and on the environment.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):171-84. PubMed ID: 15842306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician's guide to pharmacovigilance: terminology and causality assessment.
    Rehan HS; Chopra D; Kakkar AK
    Eur J Intern Med; 2009 Jan; 20(1):3-8. PubMed ID: 19237084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterinary medicines.
    Greet T
    Vet Rec; 2004 Feb; 154(9):276. PubMed ID: 15029970
    [No Abstract]   [Full Text] [Related]  

  • 12. Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countries.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):149-70. PubMed ID: 15842305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APVMA veterinary pharmacovigilance program: suspected adverse experience reports for 2005.
    Linnett PJ
    Aust Vet J; 2006 Dec; 84(12):418-20. PubMed ID: 17156321
    [No Abstract]   [Full Text] [Related]  

  • 14. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veterinary pharmacovigilance: between regulation and science.
    Keck G; Ibrahim C
    J Vet Pharmacol Ther; 2001 Dec; 24(6):369-73. PubMed ID: 11903865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing and evaluation of adverse drug experience reports at the Food and Drug Administration Center for Veterinary Medicine.
    Keller WC; Bataller N; Oeller DS
    J Am Vet Med Assoc; 1998 Jul; 213(2):208-11. PubMed ID: 9676589
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacovigilance in operation.
    Dean S
    J Small Anim Pract; 2005 May; 46(5):215. PubMed ID: 15909443
    [No Abstract]   [Full Text] [Related]  

  • 18. A new method for assessing drug causation provided agreement with experts' judgment.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Molimard M; Moore N; Haramburu F
    J Clin Epidemiol; 2006 Mar; 59(3):308-14. PubMed ID: 16488362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary medicines--suspected adverse reactions, 1997.
    Gray A
    Vet Rec; 1998 Jul; 143(3):60-1. PubMed ID: 9717219
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacovigilance for veterinary drugs in Switzerland].
    Müntener CR; Gassner B; Demuth DC; Althaus FR; Zwahlen R
    Schweiz Arch Tierheilkd; 2004 Nov; 146(11):499-505. PubMed ID: 15581284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.